Invention Grant
- Patent Title: Substituted benzimidazoles as PI3 kinase inhibitors
- Patent Title (中): 取代的苯并咪唑作为PI3激酶抑制剂
-
Application No.: US14801218Application Date: 2015-07-16
-
Publication No.: US09359352B2Publication Date: 2016-06-07
- Inventor: Pingda Ren , Yi Liu , Liansheng Li , Katrina Chan , Troy Edward Wilson , Simon Fraser Campbell
- Applicant: Intellikine LLC
- Applicant Address: US CA La Jolla
- Assignee: Intellikine LLC
- Current Assignee: Intellikine LLC
- Current Assignee Address: US CA La Jolla
- Agency: Honigman Miller Schwartz and Cohn LLP
- Agent Lucy X. Yang; Jonathan P. O'Brien
- Main IPC: C07D235/04
- IPC: C07D235/04 ; C07D471/04
Abstract:
The present invention provides substituted benzimidazole compounds of Formula I: wherein the variables R1, R2, W1, W2, W3, W4, W5, W6, Wa, Wb, Wc and Wd are defined herein. The compounds are useful as phosphoinositide 3-kinase (PI3 kinase) inhibitors.
Public/Granted literature
- US20150322064A1 Heterocyclic Compounds and Uses Thereof Public/Granted day:2015-11-12
Information query
